Eurofins Group overview
Eurofins Scientific is an international Group of life sciences companies which provide a unique range of analytical testing services to clients across multiple industries.
The Group believes it is the global leader in food, environment, pharmaceutical and cosmetic product testing, discovery pharmacology, forensics, advanced material sciences, and in agroscience Contract Research services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics and in the support of clinical studies, as well as in BioPharma Contract Development and Manufacturing. In addition, Eurofins is one of the leading global emerging players in esoteric and molecular clinical diagnostic testing. With over 61,000 staff across a network of independent companies in 61 countries generally specialised by end client markets and operating ca. 900 laboratories, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as develop and carry out innovative clinical diagnostic testing services. The Group’s objective is to provide customers with high-quality and innovative services, accurate results on time and, when requested, expert advice by its highly-qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and a very large range of testing methods.
As one of the most innovative and quality-oriented international companies in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the increasing demands of regulatory authorities and healthcare practitioners around the world.
Eurofins was founded by Dr. Gilles Martin in October 1987 with initially 3 employees. It went public in October 1997 on the Paris Stock exchange with 100 employees and celebrated its 30th anniversary in 2017 with 30 000 employees.
Since its IPO on the French stock exchange in 1997, Eurofins’ revenues have increased by 32% each year (in compound average). Eurofins is a member of the CAC 40 and Europe Stoxx 600 indices.
